(Q34184974)

English

A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Chih-Kuang Chuang

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hsiang-Yu Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tuen-Jen Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chia-Chen Tsai

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hsuan-Liang Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shuan-Pei Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Orphanet Journal of Rare Diseases

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

135

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

copyright license

Creative Commons Attribution 4.0 International

2 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Mucopolysaccharidosis I: management and treatment guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

5 July 2018

Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses

1 reference

https://api.crossref.org/works/10.1186%2FS13023-014-0135-3

21 January 2018

Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-014-0135-3

21 January 2018

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://api.crossref.org/works/10.1186%2FS13023-014-0135-3

21 January 2018

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-014-0135-3

21 January 2018

Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-014-0135-3

21 January 2018

Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-014-0135-3

21 January 2018

Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4164790

28 October 2018

Mucopolysaccharidosis I under enzyme replacement therapy with laronidase--a mortality case with autopsy report

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous determination of uronic acids, hexosamines, and galactose of glycosaminoglycans by gas-liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid and sensitive method for the analysis of carbohydrate components in glycoproteins using gas-liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential gas-liquid chromatography method for determination of uronic acids in carbohydrate mixtures

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A gas chromatographic method for the quantitative detemination of hexuronic acids in alginic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of acid mucopolysaccharides by gas chromatographic analysis of component sugars after chemical depolymerization

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy for mucopolysaccharidosis VI—experience in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI

1 reference

https://pubmed.ncbi.nlm.nih.gov/25178307

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S13023-014-0135-3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34184974&oldid=2196360656"